Unnamed: 0,title,date,stock,sentiment
298924.0,"B. Riley FBR Maintains Buy on Cormedix, Raises Price Target to $12",2020-05-12 07:45:00-04:00,CRMD,neutral
298925.0,"Cormedix Q1 EPS $(0.210) Beats $(0.230) Estimate, Sales $75.054K Miss $170.000K Estimate",2020-05-11 16:15:00-04:00,CRMD,negative
298926.0,"CorMedix Appoints Matt David, M.D. As CFO",2020-05-11 08:37:00-04:00,CRMD,neutral
298927.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,CRMD,neutral
298928.0,"B. Riley FBR Maintains Buy on Cormedix, Lowers Price Target to $10",2020-03-18 07:09:00-04:00,CRMD,negative
298929.0,Cormedix Q4 EPS $(0.21) Beats $(0.24) Estimate,2020-03-16 16:10:00-04:00,CRMD,neutral
298930.0,"The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review",2020-03-15 09:55:00-04:00,CRMD,neutral
298931.0,CorMedix Approved To Sell $5.5M Of NOL Tax Benefits Through New Jersey Economic Development Authority Program,2020-02-03 16:19:00-05:00,CRMD,positive
298932.0,CorMedix Inc. Announces FDA Grant Of Rolling Review Of Neutrolin New Drug Application,2020-02-03 08:16:00-05:00,CRMD,positive
298933.0,64 Biggest Movers From Yesterday,2019-12-19 05:03:00-05:00,CRMD,neutral
298934.0,Mid-Afternoon Market Update: FedEx Falls On Earnings Miss; Neoleukin Therapeutics Shares Climb,2019-12-18 14:10:00-05:00,CRMD,positive
298935.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-12-18 12:04:00-05:00,CRMD,neutral
298936.0,B. Riley FBR Initiates Coverage On Cormedix with Buy Rating,2019-12-18 07:12:00-05:00,CRMD,neutral
298937.0,72 Biggest Movers From Yesterday,2019-11-19 04:39:00-05:00,CRMD,neutral
298938.0,"Cormedix Q3 EPS $(1.35) Misses $(0.25) Estimate, Sales $59.53K Miss $190K Estimate",2019-11-14 16:08:00-05:00,CRMD,negative
298939.0,54 Biggest Movers From Yesterday,2019-10-17 05:52:00-04:00,CRMD,neutral
298940.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-10-16 12:35:00-04:00,CRMD,neutral
298941.0,"CorMedix Reports Completed Chemistry, Manufacturing, Controls Package For Neutrolin's New Drug Application",2019-10-16 08:16:00-04:00,CRMD,neutral
298942.0,42 Biggest Movers From Yesterday,2019-10-09 05:05:00-04:00,CRMD,neutral
298943.0,Cormedix shares are trading higher after the company reported better-than-expected Q2 EPS results.,2019-08-13 16:39:00-04:00,CRMD,positive
298944.0,"CorMedix Inc Common Stock Q2 EPS $(0.03) Beats $(0.21) Estimate, Sales $35.266K Miss $130K Estimate",2019-08-13 16:38:00-04:00,CRMD,negative
298945.0,CorMedix Highlights Presentation Of FDA Public Meeting On Limited Population Pathway For Antibacterial And Antifungal Drugs,2019-07-17 08:16:00-04:00,CRMD,negative
298946.0,Why CorMedix Shares Are Rallying,2019-07-09 11:42:00-04:00,CRMD,positive
298947.0,CorMedix Receives FDA Feedback On Neutrolin LOCK-IT-100 Data,2019-07-09 08:17:00-04:00,CRMD,neutral
298948.0,CorMedix Announces Publication Of Taurolidine Pre-Clinical Oncology Data In 'Investigational New Drugs' Journal,2019-07-08 08:32:00-04:00,CRMD,neutral
298949.0,60 Biggest Movers From Friday,2019-07-01 05:01:00-04:00,CRMD,neutral
298950.0,18 Stocks Joining The Russell Indices,2019-06-28 14:19:00-04:00,CRMD,neutral
298951.0,CorMedix Inc. Set To Join the Russell 2000 Index,2019-06-26 08:33:00-04:00,CRMD,positive
298952.0,28 Stocks Moving In Wednesday's Pre-Market Session,2019-06-26 08:08:00-04:00,CRMD,neutral
298953.0,52 Biggest Movers From Yesterday,2019-06-11 04:43:00-04:00,CRMD,neutral
298954.0,"CorMedix Inc Common Stock Q1 EPS $(0.22) Beats $(0.28) Estimate, Sales $163.692K Beat $60K Estimate",2019-05-13 16:49:00-04:00,CRMD,neutral
298955.0,71 Biggest Movers From Yesterday,2019-03-28 05:01:00-04:00,CRMD,neutral
298956.0,58 Biggest Movers From Yesterday,2019-03-27 04:22:00-04:00,CRMD,neutral
298957.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-03-26 13:20:00-04:00,CRMD,neutral
298958.0,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",2019-03-26 07:36:00-04:00,CRMD,positive
298959.0,"Cormedix Confirms 1-for-5 Reverse Split, Effective Tomorrow",2019-03-25 16:24:00-04:00,CRMD,positive
298960.0,"CorMedix Director Dillione .Buys 42,000 @ Avg Price: $1.67",2019-03-20 16:25:00-04:00,CRMD,neutral
298961.0,71 Biggest Movers From Yesterday,2019-02-15 04:59:00-05:00,CRMD,neutral
298962.0,52 Stocks Moving In Thursday's Mid-Day Session,2019-02-14 12:27:00-05:00,CRMD,neutral
298963.0,CorMedix 8-K Shows 'Cleared to Request Approval under LPAD; FDA to Review LOCK-IT-100 Clinical Data',2019-02-14 09:19:00-05:00,CRMD,positive
298964.0,Cormedix shares are trading lower after the FDA requested additional data from the company's LOCK-IT-100 study to support Cormedix's new drug application.,2019-02-14 08:56:00-05:00,CRMD,positive
298965.0,58 Biggest Movers From Yesterday,2019-02-13 04:43:00-05:00,CRMD,neutral
298966.0,Mid-Day Market Update: Crude Oil Up 3%; Bio-Path Holdings Shares Plummet,2019-01-15 12:02:00-05:00,CRMD,negative
298967.0,Cormedix Receives Approval To Sell $5.4M Of NOL Tax Benefits Through The New Jersey Economic Development Authority Program,2018-12-10 16:56:00-05:00,CRMD,positive
298968.0,"CorMedix Exec VP of Tech Operations Armstrong Buys 250,000 @ Avg Price: $1.45",2018-11-30 16:14:00-05:00,CRMD,neutral
298969.0,CorMedix Filing Shows Registration For $25M Common Stock Offering,2018-11-15 17:09:00-05:00,CRMD,neutral
298970.0,48 Biggest Movers From Yesterday,2018-10-17 05:53:00-04:00,CRMD,neutral
298971.0,40 Stocks Moving In Tuesday's Mid-Day Session,2018-10-16 12:46:00-04:00,CRMD,neutral
298972.0,"CorMedix shares are down 15.1% after the company filed for the sale of around 15 million shares of common stock, issuable upon the exercise of warrants held by selling shareholders.",2018-10-15 17:48:00-04:00,CRMD,positive
298973.0,"CorMedix S-3 Shows Filing For Sale Of Around 15M Shares Of Common Stock, Issuable Upon Exercise Of Warrants Held By Selling Stockholders",2018-10-15 17:24:00-04:00,CRMD,positive
298974.0,"Stocks Which Set New 52-Week High Yesterday, October 11th",2018-10-12 09:43:00-04:00,CRMD,neutral
298975.0,"Stocks Which Set New 52-Week High Yesterday, October 9th",2018-10-10 10:57:00-04:00,CRMD,neutral
298976.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,CRMD,neutral
298977.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,CRMD,neutral
298978.0,"CorMedix Shares Up 25%, Holding Over $0.50 Level On Extremely Heavy Volume; Not Seeing Fundamental News To Justify Move Higher; Momentum Continuing In Name: Shares Up ~86% Since $0.37 Level On Wed. Of Last Week",2018-08-30 11:32:00-04:00,CRMD,positive
298979.0,"Benzinga's Biggest Movers For The Week Of July 23, 2018",2018-07-27 16:00:00-04:00,CRMD,neutral
298980.0,50 Biggest Movers From Yesterday,2018-07-26 04:16:00-04:00,CRMD,neutral
298981.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-07-25 12:50:00-04:00,CRMD,neutral
298982.0,Mid-Morning Market Update: Markets Mostly Lower; Coca-Cola Tops Q2 Views,2018-07-25 10:14:00-04:00,CRMD,positive
298983.0,Cormedix Shares Up 58.6% Premarket After Independent Data Safety Monitoring Board Determined Statistical Significance And Efficacy In Phase 3 LOCK-IT-100 Trial For Neutrolin,2018-07-25 08:51:00-04:00,CRMD,positive
298984.0,22 Stocks Moving In Wednesday's Pre-Market Session,2018-07-25 08:01:00-04:00,CRMD,neutral
298985.0,Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board,2018-07-25 07:42:00-04:00,CRMD,positive
298986.0,Benzinga Pro's 5 Stocks To Watch Today,2018-05-30 08:35:00-04:00,CRMD,neutral
298987.0,CorMedix Reports More Than 75% Of Key Data For Neutrolin Phase 3 LOCK-IT 100 Study Has Been Reviewed And Source-Verified And Appoints Paul Chew As Consultant Adviser CMO; Shares Up 24.3% After Hours,2018-05-29 16:50:00-04:00,CRMD,positive
298988.0,"Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings",2018-05-16 08:10:00-04:00,CRMD,neutral
298989.0,"CorMedix Reports Q4 EPS $(0.15) Misses $(0.12) Est., Sales $92.53K Misses $100K; Shares Down 6.6% After Hours",2018-03-19 17:37:00-04:00,CRMD,negative
298990.0,"Earnings Scheduled For March 19, 2018",2018-03-19 04:04:00-04:00,CRMD,neutral
298991.0,CorMedix Gets Orphan Drug Designation for Taurolidine from the FDA,2018-02-23 15:03:00-05:00,CRMD,neutral
298992.0,19 Biotech Stocks With Clinical Trial Outcomes In February,2018-02-08 16:41:00-05:00,CRMD,neutral
298993.0,"UPDATE: CorMedix Says Amendment Related To When 90-Day Period Began, Amended From 90 Days After Nov. 9 To '90 calendar days after the date on which we receive a demand notice for registration of securities'",2017-12-11 09:48:00-05:00,CRMD,positive
298994.0,CorMedix 8-K Shows Co. Entered Amendment #1 To Registration Rights Deal Between Co. Elliott Associates,2017-12-11 09:47:00-05:00,CRMD,neutral
298995.0,13D/A Filing Shows Elliot Associates Reporting 6.8% Stake In CorMedix,2017-11-13 17:09:00-05:00,CRMD,neutral
298996.0,CorMedix Announces Exchanges ~962K Shares for 3.85M Warrants to Purchase Shares for $0.75/Share,2017-09-01 08:35:00-04:00,CRMD,positive
298997.0,CorMedix Announces Resignation Of Chief Medical Officer Judith Abrams,2017-08-28 17:06:00-04:00,CRMD,negative
298998.0,"CorMedix Director Kaplan Buys 80,000 @ Avg Price: $0.40 -Form4",2017-08-21 07:46:00-04:00,CRMD,neutral
298999.0,"Companies Holding Shareholder Meetings Today Include: CorMedix, Dynavax, Exeter Resource, magicJack, National Grid, Osisko Gold Royalties, and Proteon Therapeutics",2017-07-31 09:09:00-04:00,CRMD,neutral
299000.0,13G Filing from CVI Investments on CorMedix Shows 6.7% Stake,2017-05-08 12:21:00-04:00,CRMD,neutral
299001.0,13G Filing from Sabby Mgmt on CorMedix Shows 8.65% Stake,2017-05-03 11:39:00-04:00,CRMD,neutral
299002.0,20 Biggest Mid-Day Losers For Friday,2017-04-28 12:20:00-04:00,CRMD,negative
299003.0,20 Biggest Mid-Day Losers For Friday,2017-03-17 13:02:00-04:00,CRMD,negative
299004.0,Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher,2017-03-17 12:08:00-04:00,CRMD,negative
299005.0,"CorMedix Names Robert Cook CFO, Dr. Judith Abrams Chief Medical Officer",2017-02-01 08:45:00-05:00,CRMD,neutral
299006.0,"CorMedix Shares Down 16.4% After Wednesday Q3 Report: EPS $(0.23) vs Est $(0.15), Rev $44.45K vs Est $40K",2016-11-10 12:00:00-05:00,CRMD,positive
299007.0,12 Biggest Mid-Day Gainers For Tuesday,2016-10-04 12:28:00-04:00,CRMD,neutral
299008.0,Watch These 5 Huge Put Purchases In Friday Trade,2016-09-16 03:35:00-04:00,CRMD,positive
299009.0,Option Alert: CRMD Option Alert: Jan 20 $5 Puts at the bid: 885 @ 2.951 vs 130 OI,2016-09-15 10:47:00-04:00,CRMD,positive
299010.0,10 Biggest Mid-Day Gainers For Tuesday,2016-09-13 12:50:00-04:00,CRMD,neutral
299011.0,"Cormedix Says Search For New CEO Still Ongoing, Says Mulby Expected To Remain As CEO And On Board",2016-04-13 16:57:00-04:00,CRMD,neutral
299012.0,CorMedix To Present Data From Neutrolin Usage Monitoring Program On May 23,2016-04-12 13:41:00-04:00,CRMD,neutral
299013.0,"Rodman & Renshaw Maintains Buy on Cormedix, Raises PT to $7.50",2016-03-17 07:04:00-04:00,CRMD,neutral
299014.0,"CorMedix Reports Enrollment, Dosing Of Initial Patient In Phase 3 Neutrolin Trail In Hemodialysis",2015-12-14 13:40:00-05:00,CRMD,neutral
299015.0,Benzinga's Top Initiations,2015-11-12 10:08:00-05:00,CRMD,positive
299016.0,"H.C. Wainwright Initiates Coverage on Cormedix at Buy, Announces $6.50 PT",2015-11-12 07:08:00-05:00,CRMD,neutral
299017.0,"8-K Filing For CorMedix, Names James Atland Interim CFO",2015-10-30 08:08:00-04:00,CRMD,neutral
299018.0,"Pacific Premier Bancorp, Inc. Announces the Appointment of New Director",2015-10-07 06:00:00-04:00,CRMD,neutral
299019.0,8-K from Cormedix Shows CFO Harry O'Grady to Resign,2015-10-01 16:34:00-04:00,CRMD,negative
299020.0,Exclusive: Elliott's Paul Singer Says Rumors Of Yahoo Position Are Not True,2015-08-13 16:16:00-04:00,CRMD,negative
299021.0,Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold Dwindles,2015-07-20 12:03:00-04:00,CRMD,neutral
299022.0,Morning Market Losers,2015-07-20 09:53:00-04:00,CRMD,negative
299023.0,Coremedix Shares Fall 8%; May be Attributed in Part to Seeking Alpha Article,2015-06-29 11:00:00-04:00,CRMD,positive
299024.0,Morning Market Gainers,2015-06-17 09:42:00-04:00,CRMD,neutral
299025.0,CorMedix Shares Rise 20% Premarket on Announcement of Positive Feedback from FDA for Neutrolin Clinical Trial Protocol for Oncology Patients,2015-06-17 08:58:00-04:00,CRMD,positive
299026.0,CorMedix Inc. Given Positive Feedback from FDA for Neutrolin Clinical Trial Protocol for Oncology Patients,2015-06-17 08:55:00-04:00,CRMD,positive
299027.0,"Cormedix Director Lefkowitz Sells 39,072 Shares @$6.53/Share -Form 4",2015-06-01 16:29:00-04:00,CRMD,positive
299028.0,Cormedix Shares Fall 11% Following Conference Call Disclosing Delay in Ruling on Injunction vs TauroPharm in Germany,2015-05-08 10:42:00-04:00,CRMD,neutral
299029.0,"Roth Capital Downgrades Cormedix to Neutral, Raises PT to $7.50",2015-05-06 06:29:00-04:00,CRMD,neutral
299031.0,Morning Market Losers,2015-04-09 09:52:00-04:00,CRMD,negative
299032.0,CorMedix Announced Up to $100M Mixed Shelf Offering,2015-04-09 08:53:00-04:00,CRMD,neutral
299033.0,CorMedix Receives Audit Opinion with Going Concern Explanation,2015-03-31 20:01:00-04:00,CRMD,neutral
299034.0,"8-K from Cormedix Shows Co. Has Extended Taurolidine Supply Deal Mar. 31, 2016",2015-03-30 08:49:00-04:00,CRMD,neutral
299035.0,TheStreetSweeper releases a new investigative report on CorMedix,2015-03-19 10:16:00-04:00,CRMD,neutral
299036.0,CorMedix Offers Clarification for Extension of Expiration Date for Publicly-Traded Warrants,2015-03-09 09:05:00-04:00,CRMD,neutral
299037.0,Morning Market Gainers,2015-03-04 09:46:00-05:00,CRMD,neutral
299038.0,CorMedix Shares Rise 7.5% Following Announcement of Evercore Hiring to Explore Strategic Alternatives,2015-03-04 09:04:00-05:00,CRMD,positive
299039.0,"8-K from Cormedix Shows Co. Filed Complaint Against Tauropharm GmbH, Seeking a Cease & Desist Order",2015-01-20 07:11:00-05:00,CRMD,negative
299040.0,UPDATE: CorMedix Shares Resume Now Up ~15%,2015-01-15 10:43:00-05:00,CRMD,positive
299041.0,CorMedix Inc. Receives Fast Track Designation for Neutrolin,2015-01-15 10:35:00-05:00,CRMD,neutral
299042.0,CorMedix Shares Halted News Pending,2015-01-15 10:28:00-05:00,CRMD,positive
299043.0,CorMedix Inc. Files Request With FDA For QIDP Designation For Neutrolin,2014-12-04 09:23:00-05:00,CRMD,neutral
299044.0,Morning Market Movers ,2014-10-27 09:55:00-04:00,CRMD,neutral
299045.0,CorMedix Receives Approval From FDA to Initiate a Clinical Trial for Neutrolin in the US ,2014-10-27 08:53:00-04:00,CRMD,positive
299046.0,CorMedix Announces FDA IND Filing for Neutrolin in United States,2014-09-25 08:05:00-04:00,CRMD,positive
299047.0,CorMedix Reports Q2 EPS of $(0.05); Revenue of $39.7M,2014-08-14 16:48:00-04:00,CRMD,neutral
299048.0,"CorMedix Says FDA Has Agreed To Design For Phase III Neutrolin Study, Will Submit IND Within 30 Days",2014-08-14 16:46:00-04:00,CRMD,positive
299049.0,Cormedix Announces Extension of NYSE LIsting,2014-07-24 12:31:00-04:00,CRMD,neutral
299050.0,"Roth Capital Initiates Coverage on CorMedix Inc at Buy, Announces $3.00 PT",2014-07-24 09:04:00-04:00,CRMD,neutral
299051.0,Morning Market Movers ,2014-06-24 09:40:00-04:00,CRMD,neutral
299052.0,CorMedix Finalizes Phase III Study Protocol for FDA,2014-06-23 16:15:00-04:00,CRMD,neutral
299053.0,CorMedix Welcomes Additional Board Members,2014-04-07 08:33:00-04:00,CRMD,positive
299054.0,CorMedix Announces 2.96M Unit Registered Direct Offering Priced at $2.50/Unit,2014-03-05 05:41:00-05:00,CRMD,neutral
299055.0,"CorMedix to Raise $2,M in Offering ",2014-01-08 09:23:00-05:00,CRMD,neutral
299056.0,CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA ,2013-12-23 09:53:00-05:00,CRMD,neutral
299057.0,"Cormedix Reports Q2 Loss of $0.15/Share; Co. Names Gary Gelbfish as Non-Exec Chair, Anthony Pfaffle as Vice-Chair, Steven Lefkowitz as Interim CFO",2013-08-14 18:53:00-04:00,CRMD,negative
299058.0,CorMedix Shares Volatile But Largely Unch Following News of CE Mark for Neutrolin Solution,2013-07-05 11:23:00-04:00,CRMD,positive
299059.0,NASDAQ to Cancel Trades in Cormedix At or Above $0.98 Over 10:33-10:34,2013-01-29 12:39:00-05:00,CRMD,negative
299060.0,NASDAQ Investigating Potentially Erroneous Trades in Cormedix Between 10:33-10:34AM EST,2013-01-29 12:31:00-05:00,CRMD,negative
299061.0,"CorMedix Names Randy Milby as CEO, Richard Cohen as CFO; Chief Medical Officer Mark Klausner to Leave Co.",2012-12-24 09:03:00-05:00,CRMD,negative
299062.0,CorMedix: Granted Extension of NYSE Amex Listing   ,2012-07-02 16:05:00-04:00,CRMD,positive
299063.0,CorMedix Appoints Matthew Duffy to Board of Directors   ,2011-11-28 07:15:00-05:00,CRMD,neutral
299064.0,CorMedix Announces FDA Designation for Neutrolin,2011-09-29 07:30:00-04:00,CRMD,neutral
299065.0,CorMedix Announces Amended Agreement for CRMD001,2011-09-06 07:35:00-04:00,CRMD,positive
299066.0,CorMedix Submits Design Dossier for Neutrolin to Start European Approval Process   ,2011-07-07 07:57:00-04:00,CRMD,positive
299067.0,CorMedix Provides Regulatory Update For CRMD003,2011-06-23 07:43:00-04:00,CRMD,neutral
299068.0,A Peek Into The Market Before The Trading Starts,2011-06-21 07:25:00-04:00,CRMD,neutral
299069.0,CorMedix Announces SPA Agreement With FDA For Phase 3 Trial in the Prevention of Contrast-Induced Acute Kidney Injury Study With CRMD001 ,2011-06-21 07:03:00-04:00,CRMD,positive
299070.0,CorMedix Announces Successful Completion of Patient Recruitment in Phase II Contrast-Induced Acute Kidney Injury Study with CRMD001 ,2011-06-14 07:02:00-04:00,CRMD,positive
